Observational study to elucidate clinical and biological characteristics of DLBCL in AYA using registry data (NHO-DLBCL-AYA study).

Observational study to elucidate clinical and biological characteristics of DLBCL in AYA using registry data (NHO-DLBCL-AYA study). - NHOH-DLBCL-AYA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046477

Enrollment

100

Registered

2021-12-25

Start date

2021-12-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse large B-cell lymphoma (DLBCL) Primary mediastinal large B-cell lymphoma (PMBL) Burkitt lymphoma (BL)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were newly diagnosed as DLBCL, PMBL, BL based on WHO classification 2008 or WHO classification 2016 are eligible.

Exclusion criteria

Exclusion criteria: Patients who withdraw registration to this study are excluded.

Design outcomes

Primary

Measure	Time frame
Overall survival of DLBCL patients in AYA	—

Secondary

Measure	Time frame
Analysis of biological features of DLBCL in AYA by integrating with clinical information and pathological and genetic features.	—

Countries

Japan

Contacts

Public ContactYasuhiro Suzuki

National Hospital Organization Nagoya Medical Center Department of Hematology

yassuzuki@med.nagoya-u.ac.jp052-951-1111

Outcome results